GlobeNewsWire · KYTX · November 12, 2026

Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results

Get the app for more

Explore stock news, insights and company research.